Necrosis on FDG PET/CT correlates with prognosis and mortality in sarcomas

American Journal of Roentgenology

Volumn 201, Issue 1, 2013, Pages 170-177

  Rakheja, Rajan ^a   Makis, William ^b   Tulbah, Rima ^a   Skamene, Sonia ^a   Holcroft, Christina ^c   Nahal, Ayoub ^d   Turcotte, Robert ^e   Hickeson, Marc ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b Brandon Regional Health Centre   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d MONTREAL GENERAL HOSPITAL   (Canada)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

18F FDG PET CT; FDG; Necrosis; Prognosis; Sarcoma

Indexed keywords

BARIUM SULFATE; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LIMB; MAJOR CLINICAL STUDY; MALE; NECROSIS; OSTEOSARCOMA; OVERALL SURVIVAL; PELVIC GIRDLE; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SARCOMA; SHOULDER GIRDLE; SOFT TISSUE SARCOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BONE NEOPLASMS; DISEASE PROGRESSION; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; NECROSIS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOPHARMACEUTICALS; SARCOMA; SOFT TISSUE NEOPLASMS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84883341057     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.12.9795     Document Type: Article

References (25)

1. Iagaru A, Chawla S, Menendez L, Conti PS. 18FFDG PET and PET/CT for detection of pulmonary metastases from musculoskeletal sarcomas. Nucl Med Commun 2006; 27:795-802
2. Rubin BP, Fletcher CD, Inwards C, et al. Protocol for the examination of specimens from patients with soft tissue tumors of intermediate malignant potential, malignant soft tissue tumors, and benign/ locally aggressive and malignant bone tumors. Arch Pathol Lab Med 2006; 130:1616-1629
3. Pisters PW, Leung DH, Woodruff J, et al. Analysis of prognostic factors in 1041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 1996; 14:1679-1689
4. Carneiro A, Bendahl PO, Engellau J, et al. A prognostic model for soft tissue sarcoma of the extremities and trunk wall based on size, vascular invasion, necrosis and growth pattern. Cancer 2011; 117:1279-1287
5. Presant CA, Russell WO, Alexander RW, Fu YS. Soft-tissue and bone sarcoma histopathology peer review: the frequency of disagreement in diagnosis and the need for second pathology opinions-the Southeastern Cancer Study Group experience. J Clin Oncol 1986; 4:1658-1661
6. Harris M, Hartley AL, Blair V, et al. Sarcomas in north west England. I. Histopathological review. Br J Cancer 1991; 64:315-320
7. Meis-Kindblom JM, Bjerkehage B, Bohling T, et al. Morphologic review of 1000 soft tissue sarcomas from the Scandinavian Sarcoma Group (SSG) Register: the peer-review committee experience. Acta Orthop Scand Suppl 1999; 285:18-26
8. Folpe AL, Lyles RH, Sprouse JT, Conrad EU 3rd, Eary JF. (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma. Clin Cancer Res 2000; 6:1279-1287
9. Inwards CY, Unni KK. Classification and grading of bone sarcomas. Hematol Oncol Clin North Am 1995; 9:545-569
10. Coindre JM. Grading of soft tissue sarcomas: review and update. Arch Pathol Lab Med 2006; 130:1448-1453
11. Hain SF, O'Doherty MJ, Bingham J, Chinyama C, Smith MA. Can FDG PET be used to successfully direct preoperative biopsy of soft tissue tumours? Nucl Med Commun 2003; 24:1139-1143
12. Di Chiro G, Oldfield E, Wright DC, et al. Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies. AJR 1988; 150:189-197
13. Valk PE, Budinger TF, Levin VA, et al. PET of malignant cerebral tumors after interstitial brachytherapy: demonstration of metabolic activity and correlation with clinical outcome. J Neurosurg 1988; 69:830-838
14. Langleben DD, Sequall GM. PET in differentiation of recurrent brain tumor from radiation injury. J Nucl Med 2000; 41:1861-1867
15. Ferner R, Lucas J, O'Doherty M. Evaluation of 18fluorodeoxyglucose positron emission tomography (18FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis. J Neurol Neurosurg Psychiatry 2000; 68:353-357
16. Jones DN, McCowage GB, Sostman HD, et al. Monitoring of neoadjuvant therapy response of soft-tissue and musculoskeletal sarcoma using fluorine-18-FDG PET. J Nucl Med 1996; 37:1438-1444
17. Franzius C, Sciuk J, Brinkschmidt C, et al. Evaluation of chemotherapy response in primary bone tumors with F-18 FDG positron emission tomography compared with histologically assessed tumor necrosis. Clin Nucl Med 2000; 25:874-881
18. Wong CY, Nuñez R, Bohdiewicz P, et al. Patterns of abnormal FDG uptake by various histological types of non-small cell lung cancer at initial staging by PET. Eur J Nucl Med 2001; 28:1702-1705
19. Eary JF, Conrad EU, Bruckner JD, et al. Quantitative [F-18] fluorodeoxyglucose positron emission tomography in pretreatment and grading of sarcoma. Clin Cancer Res 1998; 4:1215-1220
20. Schwarzbach MH, Dimitrakopoulou-Strauss A, Willeke F. Clinical value of [18-F] fluorodeoxyglucose positron emission tomography imaging in soft tissue sarcomas. Ann Surg 2000; 231:380-386
21. Kole AC, Nieweg OE, van Ginkel RJ, et al. Detection of local recurrence of soft-tissue sarcoma with positron emission tomography using [18F]fluorodeoxyglucose. Ann Surg Oncol 1997; 4:57-63
22. Miraldi F, Adler LP, Faulhaber P. PET imaging in soft tissue sarcomas. Cancer Treat Res 1997; 91:51-64
23. Halling AC, Wollan PC, Pritchard DJ, et al. Epithelioid sarcoma: a clinicopathologic review of 55 cases. Mayo Clin Proc 1996; 71:636-642
24. Lin CN, Chou SC, Li CF, et al. Prognostic factors of myxofibrosarcomas: implications of margin status, tumor necrosis, and mitotic rate on survival. J Surg Oncol 2006; 93:294-303
25. Memorial Sloan-Kettering Cancer Center website. Sarcoma nomogram: post-surgery nomograms. mskcc.org/Sarcoma/PostSurgery.aspx. Accessed March 14, 2013